E-ISSN 1309-4866
RELATED ARTICLES
Review
Clinically Isolated Syndromes: Clinical Characteristics, Differential Diagnosis, and Management
(Arch Neuropsychiatry 2015; 52: 1-11)
DOI: 10.5152/npa.2015.12608
Cognitive Impairment in Multiple Sclerosis: Historical Aspects, Current Status, and Beyond
(Arch Neuropsychiatry 2015; 52: 12-15)
DOI: 10.5152/npa.2015.12610
Magnetic Resonance Imaging as a Major Milestone in Multiple Sclerosis Diagnosis and Treatment
(Arch Neuropsychiatry 2015; 52: 16-24)
DOI: 10.5152/npa.2015.12576
Other
Natalizumab Treatment in Multiple Sclerosis
(Arch Neuropsychiatry 2011; 48: 56-60)
DOI: 10.4274/npa.y6430
New Oral Treatments Expected to be Available for Multiple Sclerosis
(Arch Neuropsychiatry 2011; 48: 67-72)
DOI: 10.4274/npa.y6429
The Role of B Cells in Multiple Sclerosis Pathogenesis and Monoclonal Antibody Treatments Targeting B Cells
(Arch Neuropsychiatry 2011; 48: 73-78)
DOI: 10.4274/npa.y6428
Multipl Sklerozda Alemtuzumab
(Arch Neuropsychiatry 2011; 48: 79-82)
DOI: 10.4274/Npa.y6426
Symptomatic Menagement in Multiple Sclerosis
(Arch Neuropsychiatry 2011; 48: 83-89)
DOI: 10.4274/npa.Y6432
Research Article
Longitudinal Study of Cognitive Impairment in Multiple Sclerosis: A 5-year Follow-up
(Arch Neuropsychiatry 2012; 49: 29-32)
DOI: 10.4274/npa.y6088
Quality of Life, Fatigue and Balance Improvements after Home-Based Exercise Program in Multiple Sclerosis Patients
(Arch Neuropsychiatry 2012; 49: 33-38)
DOI: 10.4274/npa.y6091
The Effects of Low and Severe Disability on Walking Abilities and Quality of Life in Multiple Sclerosis Patients: 6-Month Follow-up Study
(Arch Neuropsychiatry 2013; 50: 23-29)
DOI: 10.4274/npa.y6213
Temperament and Character Traits and Alexithymia in Patients with Multiple Sclerosis
(Arch Neuropsychiatry 2013; 50: 34-39)
DOI: 10.4274/npa.y6267
Genetic Susceptibility to Multiple Sclerosis: The Role of FOXP3 Gene Polymorphism
(Arch Neuropsychiatry 2014; 51: 69-73)
DOI: 10.4274/npa.y7098
The Effects of Cognitive Rehabilitation on Relapsing Remitting Multiple Sclerosis Patients
(Arch Neuropsychiatry 2015; 52: 174-179)
DOI: 10.5152/npa.2015.7425
Cognitive Impairment in Patients with Early Relapsing-Remitting Multiple Sclerosis
(Arch Neuropsychiatry 2010; 47: 88-90)
DOI: 10.4274/npa.5416
A 12-month, Open Label, Multicenter Pilot Study Evaluating Fingolimod Treatment in terms of Patient Satisfaction in Relapsing Remitting Multiple Sclerosis Patients - FINE Trial
(Arch Neuropsychiatry ; : -)
DOI: 10.5152/npa.2017.20515
Differences Between General Neurologists and Multiple Sclerosis Specialists in the Management of Multiple Sclerosis Patients: A National Survey
(Arch Neuropsychiatry ; : -)
DOI: 10.5152/npa.2017.19387
Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients
(Arch Neuropsychiatry 2017; 54: 11-14)
DOI: 10.5152/npa.2016.12451
The Association Between Apolipoprotein E Genetic Polymorphisms and Multiple Sclerosis
(Arch Neuropsychiatry 2013; 50: 110-115)
DOI: 10.4274/npa.y6232
The Comparison of Physical Activity Status, Exercise Perception and Quality of Life Between Clinically Isolated Syndrome and Multiple Sclerosis Patients
(Arch Neuropsychiatry 2013; 50: 116-121)
DOI: 10.4274/npa.y6214
Affective Temperament Profiles in Patients with Multiple Sclerosis: Association with Mood Disorders
(Arch Neuropsychiatry 2016; 53: 311-316)
DOI: 10.5152/npa.2015.12393
Clinical, Radiological and Electrophysiological Comparison of Immunomodulatory Therapies in Multiple Sclerosis
(Arch Neuropsychiatry 2017; 54: 116-124)
DOI: 10.5152/npa.2016.12621
Validity and Reliability of the Turkish Version of the Monitoring My Multiple Sclerosis Scale
(Arch Neuropsychiatry 2017; 54: 131-136)
DOI: 10.5152/npa.2016.12694
Correlation of Fatigue with Depression, Disability Level and Quality of Life in Patients with Multiple Sclerosis
(Arch Neuropsychiatry 2015; 52: 247-251)
DOI: 10.5152/npa.2015.8714
The Prevalence of Multiple Sclerosis in the North Caucasus Region of Turkey: Door-to-Door Epidemiological Field Study
(Arch Neuropsychiatry 2012; 49: 272-275)
DOI: 10.4274/npa.y6152
Impact of Earthquake on Multiple Sclerosis Attacks
(Arch Neuropsychiatry 2010; 47: 324-327)
DOI: 10.4274/npa.y5628
Evaluation of the Adherence to Immunmodulatory Treatment in Patients with Multiple Sclerosis
(Arch Neuropsychiatry 2015; 52: 376-379)
DOI: 10.5152/npa.2015.8825
Efficacy of Different Durations of Intravenous Methylprednisolone Treatment in Relapses of Multiple Sclerosis
(Arch Neuropsychiatry 2017; 54: 57-61)
DOI: 10.5152/npa.2016.12382
Relation of Serum Uric Acid Level with Cognitive Functions and Number of Plaques in Patients with Relapsing-Remitting Multiple Sclerosis
(Arch Neuropsychiatry 2010; 47: 333-337)
DOI: 10.4274/npa.y5720
The Association of Depression with Treatment and Disability in Multiple Sclerosis
(Arch Neuropsychiatry 2012; 49: 300-303)
DOI: 10.4274/npa.y6253
Restless Legs Syndrome in Patients with Behçet’s Disease and Multiple Sclerosis: Prevalence, Associated Conditions and Clinical Features
(Arch Neuropsychiatry ; : -)
DOI: 10.5152/npa.2017.20562
The Effect of Type D Personality on Quality of Life in Patients with Multiple Sclerosis
(Arch Neuropsychiatry 2017; 54: 272-276)
DOI: 10.5152/npa.2016.12764
Intravenous Immunoglobulin Treatment for Recurrent Optic Neuritis
(Arch Neuropsychiatry ; : -)
DOI: 10.5152/npa.2017.20577
The Assessment of Sexual Dysfunction in Male Patients with Multiple Sclerosis
(Arch Neuropsychiatry ; : -)
DOI: 10.5152/npa.2017.19335
Validity and Reliability of the Turkish Version of the Multiple Sclerosis-Related Symptom Checklist
(Arch Neuropsychiatry ; : -)
DOI: 10.5152/npa.2016.16976
Comparison of Brain Atrophy, Cognition and Optical Coherence Tomography Results Between Multiple Sclerosis Patients and Healthy Controls
(Arch Neuropsychiatry ; : -)
DOI: 10.5152/npa.2017.12534
Prediction of Conversion from Clinically Isolated Syndrome to Multiple Sclerosis According to Baseline Characteristics: A Prospective Study
(Arch Neuropsychiatry ; : -)
DOI: 10.5152/npa.2017.12667
Psychosocial and Medical Determinants of Health-related Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis
(Arch Neuropsychiatry ; : -)
DOI: 10.5152/npa.2017.16983
Comparing Coloured and Black-White Visual Evoked Potentials Vep in Multiple Sclerosis Patients
(Arch Neuropsychiatry ; : -)
DOI: 10.5152/npa.2017.22787
Progressive Onset Multiple Sclerosis: Demographic, Clinical and Laboratory Characteristics of Patients with and without Relapses in the Course
(Arch Neuropsychiatry ; : -)
DOI: 10.5152/npa.2017.19269
Validity and Reliability of the Turkish Version of the Monitoring My Multiple Sclerosis Scale
(Arch Neuropsychiatry ; : -)
DOI: 10.5152/npa.2016.12694
Case Report
Organ Specific Autoimmunity in Thyroid Disorders; A Case Presentation of Thyroid Eye Disease and Monophasic CNS Manifestation
(Arch Neuropsychiatry 2011; 48: 274-276)
DOI: 10.4274/npa.y5953
Neuromyelitis Optica Spectrum Disorder in Sjogren’s Syndrome
(Arch Neuropsychiatry 2011; 48: 221-223)
DOI: 10.4274/Npa.Y5787
Multiple Sclerosis and Hashimoto’s Thyroiditis: A Case Report
(Arch Neuropsychiatry 2011; 48: 224-226)
DOI: 10.4274/Npa.Y5905
Association of Demyelinating and Inflammatory Bowel Diseases: A Case Series and Overview of the Literature
(Arch Neuropsychiatry 2015; 52: 315-318)
DOI: 10.5152/npa.2015.8725
Short Research Report
Serum Prolactin Levels in Multiple Sclerosis, Neuromyelitis Optica, and Clinically Isolated Syndrome Patients
(Arch Neuropsychiatry 2016; 53: 353-356)
DOI: 10.5152/npa.2016.16979
Key Words
Authors
All
Author's Corner
Announcements
Survey
AVES | Copyright © 2017 Turkish Neuropsychiatric Society | Latest Update: 03.10.2017